PortfoliosLab logoPortfoliosLab logo
BNGO vs. BYND
Performance
Return for Risk
Drawdowns
Volatility
Dividends
Financials

Performance

BNGO vs. BYND - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Bionano Genomics, Inc. (BNGO) and Beyond Meat, Inc. (BYND). The values are adjusted to include any dividend payments, if applicable.

Loading charts...

Returns By Period

In the year-to-date period, BNGO achieves a -15.03% return, which is significantly lower than BYND's -9.73% return.


BNGO

1D
3.17%
1M
4.84%
YTD
-15.03%
6M
-24.86%
1Y
-64.77%
3Y*
-86.03%
5Y*
-80.06%
10Y*

BYND

1D
-3.18%
1M
-21.17%
YTD
-9.73%
6M
-40.78%
1Y
-76.72%
3Y*
-58.86%
5Y*
-65.22%
10Y*
*Multi-year figures are annualized to reflect compound growth (CAGR)

BNGO vs. BYND - Yearly Performance Comparison


2026 (YTD)2025202420232022202120202019
BNGO
Bionano Genomics, Inc.
-15.03%-91.16%-84.74%-87.05%-51.17%-2.92%148.39%-68.61%
BYND
Beyond Meat, Inc.
-9.73%-78.19%-57.75%-27.70%-81.11%-47.87%65.34%14.98%

Correlation

The correlation between BNGO and BYND is 0.28, which is low. Their price movements are largely independent, making them effective diversification partners.


Correlation
Correlation (1Y)
Calculated over the trailing 1-year period

0.28

Correlation (3Y)
Calculated over the trailing 3-year period

0.26

Correlation (5Y)
Calculated over the trailing 5-year period

0.39

Correlation (All Time)
Calculated using the full available price history since May 3, 2019

0.32

The correlation between BNGO and BYND shifts across timeframes, from 0.26 (3 years) to 0.39 (5 years), reflecting how their relationship changes across market environments.

Fundamentals

EPS

BNGO:

-$6.55

BYND:

$1.03

PS Ratio

BNGO:

0.21

BYND:

0.56

Total Revenue (TTM)

BNGO:

$22.06M

BYND:

$275.50M

Gross Profit (TTM)

BNGO:

$3.32M

BYND:

$7.65M

EBITDA (TTM)

BNGO:

-$23.09M

BYND:

-$290.85M

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Return for Risk

BNGO vs. BYND — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

BNGO
BNGO Risk / Return Rank: 1111
Overall Rank
BNGO Sharpe Ratio Rank: 99
Sharpe Ratio Rank
BNGO Sortino Ratio Rank: 1010
Sortino Ratio Rank
BNGO Omega Ratio Rank: 88
Omega Ratio Rank
BNGO Calmar Ratio Rank: 99
Calmar Ratio Rank
BNGO Martin Ratio Rank: 1818
Martin Ratio Rank

BYND
BYND Risk / Return Rank: 2626
Overall Rank
BYND Sharpe Ratio Rank: 2727
Sharpe Ratio Rank
BYND Sortino Ratio Rank: 4242
Sortino Ratio Rank
BYND Omega Ratio Rank: 4242
Omega Ratio Rank
BYND Calmar Ratio Rank: 77
Calmar Ratio Rank
BYND Martin Ratio Rank: 1515
Martin Ratio Rank
The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

BNGO vs. BYND - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Bionano Genomics, Inc. (BNGO) and Beyond Meat, Inc. (BYND). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.


BNGOBYNDDifference

Sharpe ratio

Return per unit of total volatility

-0.80

-0.32

-0.48

Sortino ratio

Return per unit of downside risk

-1.09

0.53

-1.62

Omega ratio

Gain probability vs. loss probability

0.83

1.07

-0.24

Calmar ratio

Return relative to maximum drawdown

-0.83

-0.87

+0.04

Martin ratio

Return relative to average drawdown

-1.08

-1.18

+0.10

BNGO vs. BYND - Sharpe Ratio Comparison

The current BNGO Sharpe Ratio is -0.80, which is lower than the BYND Sharpe Ratio of -0.32. The chart below compares the historical Sharpe Ratios of BNGO and BYND, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.


Loading charts...

Sharpe Ratios by Period


BNGOBYNDDifference

Sharpe Ratio (1Y)

Calculated over the trailing 1-year period

-0.80

-0.32

-0.48

Sharpe Ratio (5Y)

Calculated over the trailing 5-year period

-0.89

-0.52

-0.37

Sharpe Ratio (All Time)

Calculated using the full available price history

-0.34

-0.40

+0.06

Drawdowns

BNGO vs. BYND - Drawdown Comparison

The maximum BNGO drawdown since its inception was -99.99%, roughly equal to the maximum BYND drawdown of -99.78%. Use the drawdown chart below to compare losses from any high point for BNGO and BYND.


Loading charts...

Drawdown Indicators


BNGOBYNDDifference

Max Drawdown

Largest peak-to-trough decline

-99.99%

-99.78%

-0.21%

Max Drawdown (1Y)

Largest decline over 1 year

-77.85%

-87.85%

+10.00%

Max Drawdown (3Y)

Largest decline over 3 years

-99.76%

-97.06%

-2.70%

Max Drawdown (5Y)

Largest decline over 5 years

-99.98%

-99.67%

-0.31%

Current Drawdown

Current decline from peak

-99.99%

-99.68%

-0.31%

Average Drawdown

Average peak-to-trough decline

-83.70%

-75.57%

-8.13%

Ulcer Index

Depth and duration of drawdowns from previous peaks

60.12%

65.09%

-4.97%

Volatility

BNGO vs. BYND - Volatility Comparison

The current volatility for Bionano Genomics, Inc. (BNGO) is 11.64%, while Beyond Meat, Inc. (BYND) has a volatility of 23.87%. This indicates that BNGO experiences smaller price fluctuations and is considered to be less risky than BYND based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


Loading charts...

Volatility by Period


BNGOBYNDDifference

Volatility (1M)

Calculated over the trailing 1-month period

11.64%

23.87%

-12.23%

Volatility (6M)

Calculated over the trailing 6-month period

45.02%

75.01%

-29.99%

Volatility (1Y)

Calculated over the trailing 1-year period

81.10%

236.65%

-155.55%

Volatility (5Y)

Calculated over the trailing 5-year period, annualized

90.54%

126.69%

-36.15%

Volatility (10Y)

Calculated over the trailing 10-year period, annualized

191.66%

116.24%

+75.42%

Dividends

BNGO vs. BYND - Dividend Comparison

Neither BNGO nor BYND has paid dividends to shareholders.


Tickers have no history of dividend payments

Financials

BNGO vs. BYND - Financials Comparison

This section allows you to compare key financial metrics between Bionano Genomics, Inc. and Beyond Meat, Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.


Quarterly
Annual

Total Revenue: Total amount of money received from sales and other business activities


0.0050.00M100.00M150.00M20222023202420252026
6.69K
61.59M
(BNGO) Total Revenue
(BYND) Total Revenue
Values in USD except per share items

Frequently Asked Questions


BNGO and BYND have a correlation of 0.28, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

BYND has higher volatility (23.87%) compared to BNGO (11.64%). In terms of maximum drawdown, BNGO dropped -99.99% vs BYND's -99.78%.

BYND currently has the higher Sharpe Ratio (-0.32 vs -0.80), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.

Portfolio Optimizer

Find the right allocation for BNGO and BYND

Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.

Open Portfolio Optimizer